Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -71250.0% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 888.3 | n/a |
Pr/Book | 1.5 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | n/a | (0.95) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (1.57) | (0.96)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (1.84) | (0.85)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (1.19) | (0.55)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (1.42) | (0.52)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Nanogenics Update | 03-Jul-2024 | 07:00 | RNS |
Total Voting Rights | 28-Jun-2024 | 07:00 | RNS |
Holding(s) in Company | 19-Jun-2024 | 07:00 | RNS |
N4 Pharma shares tank after £0.6m fundraise | 07-Jun-2024 | ShareCast |
N4 Pharma shares jump on latest Nuvec developments | 15-Feb-2024 | ShareCast |
N4 Pharma's Nuvec granted patent in India | 19-Jan-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 0.53p |
Change Today | 0.075p |
% Change | 16.67 % |
52 Week High | 3.07 |
52 Week Low | 0.40 |
Volume | 4,522,734 |
Shares Issued | 394.78m |
Market Cap | £2.07m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:53 | 1,507,642 @ 0.53p |
15:48 | 1,448,809 @ 0.48p |
16:24 | 34,905 @ 0.51p |
16:17 | 90,000 @ 0.55p |
16:04 | 4,392 @ 0.50p |
You are here: research